1. Currie BJ, Carapetis JR. Skin infections and infestations in Aboriginal communities in northern Australia. Australasian Journal of Dermatology 2000; 41: 139–143.
2. Gardiner DL, Sriprakash KS. Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia. Journal of Clinical Microbiology 1996; 34: 1448–1452.
3. Nimmo GR, et al. Group A streptococcal infection in an aboriginal community. Medical Journal of Australia 1992; 157: 521–522.
4. Gosbell IB. Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA). Internal Medical Journal 2005; 35 (Suppl. 2): S120–135.
5. ABS. The health and welfare of Aboriginal and Torres Strait Islander peoples. Canberra: Australia Bureau of Statistics, 2005. Report No.: 47040.0.
6. Heath DL, Panaretto KS. Nutrition status of primary school children in Townsville. Australian Journal of Rural Health 2005; 13: 282–289.
7. Vlack S, et al. Carriage of methicillin-resistant Staphylococcus aureus in a Queensland Indigenous community. Medical Journal of Australia 2006; 184: 556–559.
8. Cunningham MW. Pathogenesis of group A streptococcal infections. Clinical Microbiology Reviews 2000; 13: 470–511.
9. Facklam R, et al. emm typing and validation of provisional M types for group A streptococci. Emerging Infectious Diseases 1999; 5: 247–253.
10. McDonald MI, et al. Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection. Epidemiology and Infection. Published online: 19 February 2007. doi:10.1017/S0950268807008023.
11. Tewodros W, Kronvall G. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. Journal of Clinical Microbiology 2005; 43: 4369–4376.
12. Bisno AL. Non-suppurative poststreptococcal sequelae: rheumatic fever and glomerulonephitis. In: Mandell GL eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995, pp. 1799–1810.
13. McDonald MI, et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clinical Infectious Diseases 2006; 43: 683–689.
14. McGregor KF, et al. Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. Journal of Infectious Diseases 2004; 189: 717–723.
15. McMillan DJ, Chhatwal GS. Prospects for a group A streptococcal vaccine. Current Opinion in Molecular Therapeutics 2005; 7: 11–16.
16. Hu MC, et al. Immunogenicity of a 26-valent group A streptococcal vaccine. Infection and Immunity 2002; 70: 2171–2177.
17. McDonald M, et al. Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. Journal of Clinical Microbiology 2006; 44: 3720–3727.
18. McDonald MI, et al. The dynamic nature of group A streptococcal epidemiology in tropical communities with high rates of rheumatic heart disease. Epidemiology and Infection. Published online: 31 May 2007. doi:10.1017/S0950268807008655.